Unique Ingredient Identifier 532B59J990 is listed as a ingredient substance
| RN | 9002-89-5 |
| NCIT | C29370 |
| RXCUI | 8570 |
UNII 532B59J990 POLYVINYL ALCOHOL, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAVITREAL | IMPLANT | 0.002 % |
| ORAL | CAPSULE | 0.68 mg |
| ORAL | TABLET | 21.52 mg |
| ORAL | TABLET, DELAYED RELEASE | 3.6 mg |
| ORAL | TABLET, EXTENDED RELEASE | 7.2 mg |
| ORAL | TABLET, FILM COATED | 2.79 mg |
| AURICULAR (OTIC) | SUSPENSION, LIQUID | 0.05 % |
| INTRAMUSCULAR | INJECTION, MICROSPHERES | NA |
| INTRAOCULAR | SOLUTION | 1.4 % |
| INTRAVITREAL | IMPLANT | 0.12 MG |
| IONTOPHORESIS | DRUG DELIVERY SYSTEM | 119 MG |
| OPHTHALMIC | DROPS | 1.4 % |
| OPHTHALMIC | SOLUTION | 1.4 % |
| OPHTHALMIC | SOLUTION, DROPS | 1.4 % |
| OPHTHALMIC | SUSPENSION | 1.4 % |
| OPHTHALMIC | SUSPENSION, DROPS | 1.4 % |
| ORAL | CAPSULE, EXTENDED RELEASE | NA |
| ORAL | TABLET | 18.6 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 19.2 MG |
| ORAL | TABLET, COATED | 0.7 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 3.32 MG |
| ORAL | TABLET, DELAYED ACTION | 8.8 MG |
| ORAL | TABLET, DELAYED RELEASE | 4.64 MG |
| ORAL | TABLET, EXTENDED RELEASE | 79.4 MG |
| ORAL | TABLET, FILM COATED | 20 MG |
| ORAL | TABLET, FILM COATED | 4.8 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 2 MG |
| TOPICAL | FILM, CONTROLLED RELEASE | NA |
| TOPICAL | LOTION | NA |
| TOPICAL | PATCH | NA |
| TRANSDERMAL | DRUG DELIVERY SYSTEM | 119 MG |
| VAGINAL | EMULSION, AEROSOL FOAM | 0.5 % |
| VAGINAL | TABLET | 20.6 MG |